Role of serum HE4 as a prognostic marker in carcinoma of the ovary

CONCLUSION: HE4 levels have similar sensitivity but more specificity when compared with CA125 in diagnosing recurrent ovarian cancer. A >80% decline in HE4 levels during treatment predicts better PFS and can help in prognostication.

Source: Indian Journal of Cancer - July 18, 2019 Category: Cancer & Oncology Authors: Manikandan Lakshmanan Vijay Kumar Arun Chaturvedi Sanjeev Misra Sameer Gupta Naseem Akhtar Shiv Rajan Kavitha Jain Sudeep Garg Source Type: research